In chronic myeloid leukemia, VEGF facilitated tumor proliferation and tissue angiogenesis of leukemic and endothelial cells, which was inhibited with antisense-VEGF[64]. Here, VEGFA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.